1. Seol JE, Park IH, Lee W, Kim H, Seo JK, Oh SH. Cowden syndrome with a novel germline PTEN mutation and an unusual clinical course. Ann Dermatol. 2015; 27:306–309. PMID:
26082588.
2. Hong EJ, Kim HK, Cho YS, Ji JS, Kim CW, Kim CW, et al. A case of Cowden syndrome associated with breast cancer and thyroid cancer. Korean J Gastrointest Endosc. 2006; 32:293–297.
3. Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013; 105:1607–1616. PMID:
24136893.
Article
4. Lee HR, Moon YS, Yeom CH, Kim KW, Chun JY, Kim HK, et al. Cowden's disease--a report on the first case in Korea and literature review. J Korean Med Sci. 1997; 12:570–575. PMID:
9443100.
Article
5. Bagan JV, Peñarrocha M, Vera-Sempere F. Cowden syndrome: clinical and pathological considerations in two new cases. J Oral Maxillofac Surg. 1989; 47:291–294. PMID:
2921660.
Article
6. Ward SK, Roenigk HH, Gordon KB. Dermatologic manifestations of gastrointestinal disorders. Gastroenterol Clin North Am. 1998; 27:615–636. viPMID:
9891700.
Article
7. Gustafson S, Zbuk KM, Scacheri C, Eng C. Cowden syndrome. Semin Oncol. 2007; 34:428–434. PMID:
17920899.
Article
8. Salem OS, Steck WD. Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. J Am Acad Dermatol. 1983; 8:686–696. PMID:
6863628.
9. Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet. 2000; 37:828–830. PMID:
11073535.
Article
10. Hildenbrand C, Burgdorf WH, Lautenschlager S. Cowden syndrome-diagnostic skin signs. Dermatology. 2001; 202:362–366. PMID:
11455162.
11. Brownstein MH, Mehregan AH, Bikowski JB. Trichilemmomas in Cowden's disease. JAMA. 1977; 238:26.
Article
12. Hong WK, Song HJ, Lee HS, Lee jR, Shin JH, Choi GS. A case of Cowden syndrome. Korean J Dermatol. 2007; 45:829–831.
13. Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet. 1996; 13:114–116. PMID:
8673088.
Article
14. Celebi JT, Shendrik I, Silvers DN, Peacocke M. Identification of PTEN mutations in metastatic melanoma specimens. J Med Genet. 2000; 37:653–657. PMID:
10978354.
Article
15. Stewart AL, Mhashilkar AM, Yang XH, Ekmekcioglu S, Saito Y, Sieger K, et al. PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells. Mol Med. 2002; 8:451–461. PMID:
12435856.
16. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005; 42:318–321. PMID:
15805158.
Article
17. Varga EA, Pastore M, Prior T, Herman GE, McBride KL. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med. 2009; 11:111–117. PMID:
19265751.
Article
18. Danielsen SA, Lind GE, Bjørnslett M, Meling GI, Rognum TO, Heim S, et al. Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- status. Hum Mutat. 2008; 29:E252–E262. PMID:
18781614.
19. Kwong A, Shin VY, Au CH, Law FB, Ho DN, Ip BK, et al. Detection of germline mutation in hereditary breast and/or ovarian cancers by next-generation sequencing on a four-gene panel. J Mol Diagn. 2016; 18:580–594. PMID:
27157322.
Article